Sales de-grew by 2.78%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Standalone Financials)
Centenial Surgical Suture Share Price
Centenial Surgical Sutu...
Centenial Surg share price insights
Stock gave a 3 year return of 117.84% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
Company has spent 4.82% of its operating revenues towards interest expenses and 22.14% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
Stock generated 117.84% return as compared to BSE Healthcare which gave investors 64.6% return over 3 year time period. (as of last trading session)
Centenial Surgical Suture Ltd. share price moved up by 8.11% from its previous close of Rs 109.00. Centenial Surgical Suture Ltd. stock last traded price is 117.85
Share Price Value Today/Current/Last 117.85 Previous Day 109.00
Key Metrics
PE Ratio (x) | 41.70 | ||||||||||
EPS - TTM (₹) | 2.83 | ||||||||||
MCap (₹ Cr.) | 43.00 | ||||||||||
Sectoral MCap Rank | 40 | ||||||||||
PB Ratio (x) | 1.23 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| 0.00 | ||||||||||
VWAP (₹) | 115.16 | ||||||||||
52W H/L (₹) |
Centenial Surg Share Price Returns
1 Day | 8.11% |
1 Week | 9.78% |
1 Month | N.A. |
3 Months | 8.12% |
1 Year | 54.68% |
3 Years | 117.84% |
5 Years | N.A. |
Centenial Surg News & Analysis
- Announcements
- Announcements
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
AnnouncementsAnnouncement under Regulation 30 (LODR)-Newspaper Publication
Announcements
Centenial Surg Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Centenial Surg Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
Topline Contraction
Sales de-grew by 2.78%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Standalone Financials)Employee & Interest Expense
Company has spent 4.82% of its operating revenues towards interest expenses and 22.14% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
Quarterly | Annual Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 13.74 12.08 12.45 13.12 13.67 Total Income Growth (%) 13.69 -2.92 -5.13 -3.99 4.74 Total Expenses 12.81 10.98 11.53 12.27 12.79 Total Expenses Growth (%) 16.62 -4.72 -6.06 -4.06 4.54 EBIT 0.93 1.10 0.92 0.85 0.87 EBIT Growth (%) -15.52 19.62 8.33 -2.95 7.62 Profit after Tax (PAT) 0.30 0.19 0.31 0.24 0.29 PAT Growth (%) 56.78 -37.92 29.67 -18.99 107.62 EBIT Margin (%) 6.76 9.10 7.39 6.47 6.40 Net Profit Margin (%) 2.17 1.57 2.46 1.80 2.13 Basic EPS (₹) 0.82 0.52 0.84 0.65 0.80 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 79.15 66.40 61.34 70.05 69.29 Total Assets Growth (%) 19.20 8.25 -12.43 1.10 22.08 Total Liabilities 46.93 35.32 31.14 40.47 40.68 Total Liabilities Growth (%) 32.87 13.42 -23.05 -0.52 41.69 Total Equity 32.22 31.08 30.20 29.57 28.61 Total Equity Growth (%) 3.67 2.91 2.13 3.36 1.96 Current Ratio (x) 1.99 2.04 2.20 1.92 1.87 Total Debt to Equity (x) 0.00 0.32 0.31 0.42 0.00 Contingent Liabilities 0.00 0.10 0.10 0.10 0.10 All figures in Rs Cr, unless mentioned otherwise
Insights
Increase in Cash from Investing
Company has used Rs 7.92 cr for investing activities which is an YoY increase of 4407.31%. (Source: Standalone Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 3.75 1.30 4.75 -0.05 2.08 Net Cash used in Investing Activities -7.92 -0.18 -0.17 -0.89 -1.31 Net Cash flow from Financing Activities 4.53 -1.05 -4.87 0.75 -0.37 Net Cash Flow 0.35 0.07 -0.28 -0.18 0.40 Closing Cash & Cash Equivalent 0.68 0.33 0.26 0.54 0.72 Closing Cash & Cash Equivalent Growth (%) 107.45 28.65 -52.39 -25.48 121.61 Total Debt/ CFO (x) 0.00 7.65 1.96 -254.10 0.00 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 3.52 2.85 2.07 3.25 4.52 Return on Capital Employed (%) 8.08 8.37 8.00 9.20 11.31 Return on Assets (%) 1.43 1.33 1.02 1.37 1.87 Interest Coverage Ratio (x) 2.08 2.66 2.37 2.53 1.99 Asset Turnover Ratio (x) 0.70 0.82 0.68 0.53 80.26 Price to Earnings (x) 43.86 37.88 52.63 24.15 14.58 Price to Book (x) 1.54 1.08 1.09 0.78 0.66 EV/EBITDA (x) 9.53 9.72 9.35 6.85 3.08 EBITDA Margin (%) 10.02 8.40 10.11 13.80 10.59
Centenial Surg Peer Comparison
Centenial Surg Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 117.84% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)Stock Returns vs BSE Healthcare
Stock generated 117.84% return as compared to BSE Healthcare which gave investors 64.6% return over 3 year time period. (as of last trading session)
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 117.84% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)Stock Returns vs BSE Healthcare
Stock generated 117.84% return as compared to BSE Healthcare which gave investors 64.6% return over 3 year time period. (as of last trading session)
See All Parameters
MF Ownership
MF Ownership details are not available.
Corporate Actions
Centenial Surg Board Meeting/AGM
Centenial Surg Dividends
- Others
Meeting Date Announced on Purpose Details Aug 12, 2024 Aug 05, 2024 Board Meeting Quarterly Results & A.G.M. May 28, 2024 May 21, 2024 Board Meeting Audited Results Apr 29, 2024 Apr 25, 2024 Board Meeting Others Feb 14, 2024 Feb 07, 2024 Board Meeting Quarterly Results Nov 14, 2023 Oct 30, 2023 Board Meeting Quarterly Results Dividend announcements are not available.
No other corporate actions details are available.
About Centenial Surg
Centenial Surgical Suture Ltd., incorporated in the year 1995, is a Small Cap company (having a market cap of Rs 43.00 Crore) operating in Hospitals & Allied Services sector. Centenial Surgical Suture Ltd. key Products/Revenue Segments include Medical Equipments & Accessories for the year ending 31-Mar-2023. Show More
Executives
Auditors
- VM
Vijay Majrekar
Managing Director & CEOAKAnuradha Kashikar
Executive Director & CFODTDevraj T Poojary
Executive DirectorBSBhushan S Limaye
Ind. Non-Executive DirectorShow More - Mahesh Chandra & Associates
Industry
Key Indices Listed on
-
Address
F-29, MIDC,MurbadThane, Maharashtra - 421401
More Details
FAQs about Centenial Surg share
- 1. What's the Centenial Surg share price today?Centenial Surg share price was Rs 117.85 as on 29 Aug, 2024, 03:31 PM IST. Centenial Surg share price was up by 8.11% based on previous share price of Rs 112.75. Centenial Surg share price trend:
- Last 3 Months: Centenial Surg share price moved up by 8.12%
- Last 12 Months: Centenial Surg share price moved up 54.68%
- Last 3 Years: Centenial Surg Share price moved up by 117.84%
- 2. What are the Centenial Surg quarterly results?Total Revenue and Earning for Centenial Surg for the year ending 2024-03-31 was Rs 51.32 Cr and Rs 1.13 Cr on Standalone basis. Last Quarter 2024-06-30, Centenial Surg reported an income of Rs 13.74 Cr and profit of Rs 0.30 Cr.
- 3. Who's the owner of Centenial Surg?Following are the key changes to Centenial Surg shareholding:
- Promoter holding has not changed in last 9 months and holds 46.89 stake as on 30 Jun 2024
- Other investor holding has not changed in last 9 months and holds 53.11 stake as on 30 Jun 2024
- 4. What are the returns for Centenial Surg share?Return Performance of Centenial Surg Shares:
- 1 Week: Centenial Surg share price moved up by 9.78%
- 3 Month: Centenial Surg share price moved up by 8.12%
- 6 Month: Centenial Surg share price moved up by 12.61%
- 5. What has been highest price of Centenial Surg share in last 52 weeks?Centenial Surg share price saw a 52 week high of Rs 160.00 and 52 week low of Rs 73.46.
- 6. Who is the Chief Executive Officer of Centenial Surg?Vijay Majrekar is the Managing Director & CEO of Centenial Surg
- 7. Which are the key peers to Centenial Surg?Within Hospitals & Allied Services sector Centenial Surg, Bandaram Pharma Packtech Ltd., Shree Pacetronix Ltd., GKB Ophthalmics Ltd., Kretto Syscon Ltd., Span Divergent Ltd., Transgene Biotek Ltd., Transpact Enterprises Ltd., Constronics Infra Ltd., Denis Chem Lab Ltd. and Nureca Ltd. are usually compared together by investors for analysis.
- 8. What are the key metrics to analyse Centenial Surg Share Price?Centenial Surg share can be quickly analyzed on following metrics:
- Stock's PE is 41.70
- Price to Book Ratio of 1.23
- 9. What's the market capitalization of Centenial Surg?Market Capitalization of Centenial Surg stock is Rs 43.00 Cr.
- 10. What is the PE & PB ratio of Centenial Surg?The PE ratio of Centenial Surg stands at 38.57, while the PB ratio is 1.84.
- 11. What is the CAGR of Centenial Surg?The CAGR of Centenial Surg is 8.5.
Trending in Markets
Centenial Surg Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.